Archive – Multinational Companies

Tariff impact on Swiss economy concerns public

Confidence in the Swiss economy is stagnating, according to a study

This content was published on Apr 26, 2025 The Swiss public worries that United States tariffs will damage the Alpine state's reputation as a business location.

Novartis and Sanofi call for higher drug prices in Europe

This content was published on Apr 23, 2025 Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.

Roche gets EU green light to detect heart attacks

Swiss pharma giant Roche secures CE mark for chest pain triage algorithm

This content was published on Apr 23, 2025 The test is designed to help A&E doctors make safe decisions about ruling out or confirming heart attacks.

Photo of man speaking in front of WEF panel

WEF reportedly investigates founder Klaus Schwab

This content was published on Apr 23, 2025 The Wall Street Journal reported that Schwab and his wife are accused of using WEF funds for personal expenses.

A timeline on a wall at an exhibition space.

From Jung to psychedelics: a timeline of Switzerland’s contributions to psychiatry

This content was published on Apr 23, 2025 From the synthesisation of LSD to the commercialisation of antidepressants, Switzerland has played a key role in the understanding and treatment of psychiatry.

A psilocybin mushroom held by a hand in a glove.

Switzerland is home to Europe’s only psychedelics treatment

This content was published on Apr 23, 2025 Doctors at Swiss hospitals and private practices are turning to alternative methods such as psychedelics. But the therapies are costly, rare and sometimes informal.

Ypsomed sells diabetes business to TecMed

Swiss medical device maker Ypsomed to sell diabetes business

This content was published on Apr 22, 2025 Bern-based injection device manufacturer Ypsomed announced on Tuesday that it was selling its diabetes-related activities.

UBS enters into local partnership in India for wealth management

This content was published on Apr 22, 2025 UBS has entered into a strategic partnership in India to expand its wealth management business.

Roche plans to invest 50 billion dollars in the USA within 5 years

Swiss pharma giant Roche to invest $50bn in US within five years

This content was published on Apr 22, 2025 After Novartis, fellow Swiss pharmaceutical company Roche plans to invest up to $50 billion in the US over the next five years.

CF: US duties, Swiss economy slowing but no slump

Swiss economy impacted by US tariffs but no crisis

This content was published on Apr 16, 2025 United States tariffs will lead to a sharp weakening of the Swiss economy, but not to a collapse, the government says.

Archive – Multinational Companies

Popular Stories

Most Discussed

Archive – Multinational Companies

More

Tariff impact on Swiss economy concerns public

More

Novartis and Sanofi call for higher drug prices in Europe

More

Swiss pharma giant Roche secures CE mark for chest pain triage algorithm

More

WEF reportedly investigates founder Klaus Schwab

More

From Jung to psychedelics: a timeline of Switzerland’s contributions to psychiatry

More

Switzerland is home to Europe’s only psychedelics treatment

More

Swiss medical device maker Ypsomed to sell diabetes business

More

UBS enters into local partnership in India for wealth management

More

Swiss pharma giant Roche to invest $50bn in US within five years

More

Swiss economy impacted by US tariffs but no crisis

Popular Stories

Most Discussed